Precision Medicine

Profusa launches its Lumee system for research, aiming to capture a piece of the $47B CRO market and revolutionize drug development with real-time data.

A landmark Nature Medicine publication for OrsoBio's TLC-2716 offers new hope for millions suffering from severe lipid and liver disorders.

Kaiser Permanente hires veteran strategist Beth Leonard for a new C-suite role, signaling a major push to influence policy and export its care model.

The global digital immunoassay market is set to triple, promising to find diseases earlier than ever. But can healthcare systems overcome the high cost?

Jennifer Erickson, a mentee of the retiring CEO, returns to lead Arizona's top lab, signaling a new era of innovation amid industry-wide shifts.

Basketball legends and the Prostate Cancer Foundation unite in a new initiative to fight late detection, urging men of color to prioritize life-saving screenings.

InterAx's AI platform and Alveus's R&D expertise combine in a new partnership to develop a next-gen obesity drug with durable results and better tolerability.

The Korean biopharma giant is leveraging its biosimilar success to fund a major push into cutting-edge cancer therapies and advanced drug platforms.

Reimbursements are falling and costs are rising, but top allergy practices are boosting revenue by 22%. A new report reveals their data-driven secrets.

A new alliance in healthcare marketing merges pharmaceutical expertise with provider-side insights, leveraging AI and big data to fix a fragmented system.

Adial Pharmaceuticals files a key patent to protect its personalized Alcohol Use Disorder drug, AD04, until 2045, signaling a new era for addiction medicine.

Amid rising costs and staffing crises, ApolloMD promotes veteran insiders to lead operations and revenue cycle, betting on experience to ensure stability.

With major funding and a seasoned CEO, Caldera Therapeutics is advancing a first-in-class bispecific antibody into the clinic for inflammatory bowel disease.

A new partnership aims to bring a revolutionary, disease-modifying stem cell therapy for knee osteoarthritis to millions of patients in Greater China.

A new partnership reveals how integrating mental health is revolutionizing oncology, improving patient outcomes, and setting a new standard for whole-person care.

O Positiv's new menopause and metabolism products at Target signal a market shift. But how strong is the science behind these 'clinically studied' formulas?

WNBA star Erica Wheeler lost her mom to cervical cancer. Now, she's teaming up with Hologic to tackle a worrying rise in cases and save lives.

Propanc Biopharma is taking a 100-year-old cancer treatment concept into modern human trials, targeting advanced tumors and expanding into fibrosis.

As Disc Medicine nears a potential drug launch, its new HR chief hire reveals a critical strategy for navigating biotech's intense talent wars.

Metta Lou Henderson and Steve Simenson are recognized for their transformative leadership and innovative patient care, shaping the future of pharmacy.